PVS-10200

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePVS-10200

Drug Alias NamePVS-10200

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Aortic endothelial cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsPeripheral Arterial Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesShire Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShire

Active IndicationsN/A

Inactive IndicationsPeripheral Arterial Disease

Other Information

ATC CodeN/A